We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 23
Most popular |Most recent


CJEU rules on whether the NHS reimbursing off-label medicinal products for cost-cutting purposes conflicts with Directive 200183EC

European Union, Italy - November 23 2018 Novartis Farma S.p.A. v Italian Medicines Agency and Roche Italia S.p.A. On 21 November 2018, the CJEU issued an important decision in Novartis Farma...

Sara Balice, Spartak Kodra.


UK Supreme Court raises sufficiency standard for swiss-form claims and limits the ability to assert them against “skinny label” products

United Kingdom - November 15 2018 Yesterday's Supreme Court decision in Warner-Lambert v Mylan is disappointing news for patentees who may have made significant investment in R&D to...

Alex Freelove.


Patent and Pharma Update - October 2018

United Kingdom, Bulgaria, European Union - October 11 2018 In our last Patent and Pharma update, we reported on the opinion of Advocate General Wathelet (the “AG”) on the interpretation of Article 3(a) of the...

Krishna Kakkaiyadi, Rachel Montagnon.


EPO publishes 2018 revision of Guidelines for Examination directed to computer-implemented inventions

European Union - October 10 2018 The EPO has recently published the 2018 revision to its Guidelines for Examination, which are generally updated annually to take into account...

Krishna Kakkaiyadi, Julie Chiu.


UK Government launches consultation on role of MHRA post-Brexit and confirms commitment to underwrite Horizon 2020 funding

United Kingdom - October 4 2018 The UK Government has today launched a consultation on the role of the Medicines and Healthcare products Regulatory Agency (MHRA) post-Brexit “seeking...

Rachel Montagnon.